Koyfin Home > Directory > Health Care > Acorda Therapeutics > Diluted EPS Excl. Extra Items

Acorda Therapeutics Diluted EPS Excl. Extra Items Chart (ACOR)

Acorda Therapeutics annual/quarterly Diluted EPS Excl. Extra Items from 2010 to 2020. Earnings per share (EPS) is the portion of a company's profit allocated to each outstanding share of common stock. Earnings per share serves as an indicator of a company's profitability. EPS is calculated as: EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.
  • Acorda Therapeutics Diluted EPS Excl. Extra Items for the quarter ending June 06, 2020 was $0m a -1,400.00% increase of 5m year over year
  • Acorda Therapeutics Diluted EPS Excl. Extra Items for the last 12 months ending June 06, 2020 was $-5m a -48.62% increase of 2m year over year
  • Acorda Therapeutics Annual Diluted EPS Excl. Extra Items for 2019 was $-6m a 112.35% decrease of -6m from 2018
  • Acorda Therapeutics Annual Diluted EPS Excl. Extra Items for 2018 was $1m a 784.51% increase of 6m from 2017
  • Acorda Therapeutics Annual Diluted EPS Excl. Extra Items for 2017 was $-5m a 84.26% decrease of -4m from 2016
Other Per Share Metrics:
  • Acorda Therapeutics Diluted EPS Incl. Extra Items for the quarter ending December 12, 2018 was $0m a 190.00% increase of 0m year over year
View Chart On Koyfin

Quarterly ACOR Diluted EPS Excl. Extra Items Data

06/2020$0m
03/2020$0m
12/2019$1m
09/2019$-6m
06/2019$-1m
03/2019$-1m
12/2018$0m
09/2018$0m
06/2018$1m
03/2018$0m

Annual ACOR Diluted EPS Excl. Extra Items Data

2019$-6m
2018$1m
2017$-5m
2016$-1m
2015$0m
2014$0m
2013$0m
2012$4m
2011$1m
2010$0m